Russia Successfully complete trial of first COVID-19 Vaccine.

In MOSCOW state of clinical trail of vaccine which is produced by Russian institute of Epidemiology and microbiology on 18th June. The university has completed test and it was world first vaccine against by the coronvirus .

The director of the MOSCOW university of Medical Parasitology, Tropical and Vector- Borne Diseases at sechenov, the objective of the stage of the way to the vaccine’s safety for human health, which was the successfully done. “The vaccine is confirmed. Lukashev told to sputnik for the safety of those vaccine that are in market. The vaccine development situation with the possibility of scaling up production.

The pandemic situation acted as only the institution but as a scientific and research technology center is the creation must important and complex produce as a drug. Vaccine is starting preclinical studies and protocol development, and clinical trial are currently underway.

The first trial of first group of 18 volunteers group of 23 volunteers. All volunteers, who were between ages of 18 to 65, has the spend 28 days in isolation, in the prevent them from of contracting to other infections. They are will be monitored for 6 months of their discharge as well.

VACCINE AND TREATMENT FOR COVID -19. Vaccine The world Health Organization is lists of the Russian vaccine in their are three phases in 1 of the clinical trial and any vaccine get approved of large scale production, undergo of three human trials.

The 9 Lakh marks in India and highly contagious virus which is a already claimed more than 23000 thousand of people lives.As the 8 May, two medications Trusted source had received emergency use authorization (EUA) from the food and Drug Administration (FDA). The remdesivir and a drug used to sedate people on a ventilator.

The EUA March for the antimalarial drugs chloro quine and hydrocholoro quine, but later revoked it Trusted Source after studies showed that they are unlikely be effective in treatment for COVID-19. An EUA allows doctor use to the drugs to treatment people with COVID-19 even before the medication have through the formal FDA approval process.

These drugs are still the beings tested trials to see the whether they are effective COVID – 19. This steps is needed to make the sure the medications are safe for this particular use and what proper dosses should be. It could be month before treatment area available that are known against COVID- 19. It could be even longer for the vaccine.

EIDD – 2801 This drug was creat by scientists at a nonprofit biotech owned by the Emory university. Research in mice has shown that it can reduce replication of multiple corona virus. Pharmaceutical company Merck and Ridge back Bioterapeutics LP signed an agreement in may to develop this drug. It already being tested in a clinical trial in the united kingdom. Unlike remdesivir, EIDD-2801 can be taken orally, which would, make it available to a larger number of people.

MERIMEPODIB (VX-497)

This drugs are development by the Viral Clear Pharmaceutical. has been shown by previously to have antiviral and immune- suppressing effects. It was tested against hepatits C but had only modest effects

The company is running a phase II trial of this drug. People with their will be randomized to receiver either by the merimepodib with placebo. The company hope have to result by late summer of this year.